...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers

"Wow! Synergy of apabetalone with SGLT2 inhibitors on renal function and glucose control.....in addition to the MACE data!!! "

So Apabetalone is patent protected till 2040? Is that about right?

 

Koo

Share
New Message
Please login to post a reply